{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:40:55Z","timestamp":1787020855521,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T00:00:00Z","timestamp":1709942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T00:00:00Z","timestamp":1709942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Shaanxi Provincial Traditional Chinese Medicine Administration Double Chain Integration Middle Youth Research and Innovation Team Project","award":["2022-SLRH-LJ-007"],"award-info":[{"award-number":["2022-SLRH-LJ-007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Studies have suggested that blood circulating phytosterols, plant-derived sterols analogous to cholesterol, were associated with blood lipid levels and the risk of Alzheimer\u2019s disease (AD) and Parkinson\u2019s disease (PD). This Mendelian randomization (MR) study is performed to determine the causal effect of circulating phytosterols on AD and PD and evaluate the mediation effect of blood lipids.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Leveraging genome-wide association studies summary-level data for phytosterols, blood lipids, AD, and PD, univariable and multivariable MR (MVMR) analyses were conducted. Four types of phytosterols (brassicasterol, campesterol, sitosterol, and stigmasterol), three blood lipids parameters (high-density lipoprotein cholesterol [HDL-C], non-HDL-C, and triglyceride), two datasets for AD and PD were used. Inverse-variance weighted method was applied as the primary analysis, and false discovery rate method was used for adjustment of multiple comparisons.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Using the largest AD dataset, genetically proxied higher levels of stigmasterol (OR\u2009=\u20090.593, 95%CI\u2009=\u20090.431\u20130.817,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.004) and sitosterol (OR\u2009=\u20090.864, 95%CI\u2009=\u20090.791\u20130.943,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.004) significantly correlated with a lower risk of AD. No significant associations were observed between all four types of phytosterols levels and PD. MVMR estimates showed that the above causal associations were missing after integrating the blood lipids as exposures. Sensitivity analyses confirmed the robustness of these associations, with no evidence of pleiotropy and heterogeneity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The study supports a potential beneficial role of blood stigmasterol and sitosterol in reducing the risk of AD, but not PD, which is dependent on modulating blood lipids. These insights highlight circulating stigmasterol and sitosterol as possible biomarkers and therapeutic targets for AD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-024-01424-9","type":"journal-article","created":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T00:01:22Z","timestamp":1709942482000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Deciphering the effect of phytosterols on Alzheimer\u2019s disease and Parkinson\u2019s disease: the mediating role of lipid profiles"],"prefix":"10.1186","volume":"16","author":[{"given":"Xingzhi","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,9]]},"reference":[{"issue":"10248","key":"1424_CR1","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","volume":"396","author":"G Livingston","year":"2020","unstructured":"Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, Brayne C, Burns A, Cohen-Mansfield J, Cooper C, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396(10248):413\u201346.","journal-title":"Lancet"},{"key":"1424_CR2","doi-asserted-by":"publisher","first-page":"603854","DOI":"10.3389\/fnagi.2020.603854","volume":"12","author":"L Cui","year":"2020","unstructured":"Cui L, Hou NN, Wu HM, Zuo X, Lian YZ, Zhang CN, Wang ZF, Zhang X, Zhu JH. Prevalence of Alzheimer\u2019s Disease and Parkinson\u2019s Disease in China: an updated Systematical Analysis. Front Aging Neurosci. 2020;12:603854.","journal-title":"Front Aging Neurosci"},{"issue":"10291","key":"1424_CR3","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C. Parkinson\u2019s disease. Lancet. 2021;397(10291):2284\u2013303.","journal-title":"Lancet"},{"issue":"4","key":"1424_CR4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41570-021-00254-9","volume":"5","author":"K Kulenkampff","year":"2021","unstructured":"Kulenkampff K, Wolf Perez AM, Sormanni P, Habchi J, Vendruscolo M. Quantifying misfolded protein oligomers as drug targets and biomarkers in Alzheimer and Parkinson diseases. Nat Rev Chem. 2021;5(4):277\u201394.","journal-title":"Nat Rev Chem"},{"issue":"1","key":"1424_CR5","doi-asserted-by":"publisher","first-page":"e10367","DOI":"10.1002\/btm2.10367","volume":"8","author":"P Chopade","year":"2023","unstructured":"Chopade P, Chopade N, Zhao Z, Mitragotri S, Liao R, Chandran Suja V. Alzheimer\u2019s and Parkinson\u2019s disease therapies in the clinic. Bioeng Transl Med. 2023;8(1):e10367.","journal-title":"Bioeng Transl Med"},{"key":"1424_CR6","doi-asserted-by":"publisher","first-page":"746211","DOI":"10.3389\/fnmol.2021.746211","volume":"14","author":"M Jose","year":"2021","unstructured":"Jose M, Sivanand A, Channakeshava C. Membrane cholesterol is a critical determinant for hippocampal neuronal polarity. Front Mol Neurosci. 2021;14:746211.","journal-title":"Front Mol Neurosci"},{"issue":"10","key":"1424_CR7","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1096\/fj.00-0815fje","volume":"15","author":"AR Koudinov","year":"2001","unstructured":"Koudinov AR, Koudinova NV. Essential role for cholesterol in synaptic plasticity and neuronal degeneration. Faseb j. 2001;15(10):1858\u201360.","journal-title":"Faseb j"},{"issue":"5","key":"1424_CR8","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1007\/s12035-020-02232-6","volume":"58","author":"L Dai","year":"2021","unstructured":"Dai L, Zou L, Meng L, Qiang G, Yan M, Zhang Z. Cholesterol metabolism in neurodegenerative diseases: Molecular mechanisms and therapeutic targets. Mol Neurobiol. 2021;58(5):2183\u2013201.","journal-title":"Mol Neurobiol"},{"issue":"6","key":"1424_CR9","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1080\/15548627.2021.1920814","volume":"17","author":"V Roca-Agujetas","year":"2021","unstructured":"Roca-Agujetas V, de Dios C, Abadin X, Colell A. Upregulation of brain cholesterol levels inhibits mitophagy in Alzheimer disease. Autophagy. 2021;17(6):1555\u20137.","journal-title":"Autophagy"},{"issue":"37","key":"1424_CR10","doi-asserted-by":"publisher","first-page":"6750","DOI":"10.2174\/0929867325666180706113844","volume":"26","author":"T Dierckx","year":"2019","unstructured":"Dierckx T, Bogie JFJ, Hendriks JJA. The impact of phytosterols on the healthy and diseased brain. Curr Med Chem. 2019;26(37):6750\u201365.","journal-title":"Curr Med Chem"},{"issue":"13","key":"1424_CR11","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1080\/10408398.2020.1867819","volume":"62","author":"F Jie","year":"2022","unstructured":"Jie F, Yang X, Wu L, Wang M, Lu B. Linking phytosterols and oxyphytosterols from food to brain health: origins, effects, and underlying mechanisms. Crit Rev Food Sci Nutr. 2022;62(13):3613\u201330.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"37","key":"1424_CR12","doi-asserted-by":"publisher","first-page":"6704","DOI":"10.2174\/0929867326666190822154701","volume":"26","author":"L Ced\u00f3","year":"2019","unstructured":"Ced\u00f3 L, Farr\u00e0s M, Lee-Rueckert M, Escol\u00e0-Gil JC. Molecular insights into the mechanisms underlying the cholesterol- lowering effects of Phytosterols. Curr Med Chem. 2019;26(37):6704\u201323.","journal-title":"Curr Med Chem"},{"issue":"3","key":"1424_CR13","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2174\/1381612826666200628022812","volume":"27","author":"R Dash","year":"2021","unstructured":"Dash R, Mitra S, Ali MC, Oktaviani DF, Hannan MA, Choi SM, Moon IS. Phytosterols: Targeting Neuroinflammation in Neurodegeneration. Curr Pharm Des. 2021;27(3):383\u2013401.","journal-title":"Curr Pharm Des"},{"issue":"3","key":"1424_CR14","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/j.1600-0447.2011.01713.x","volume":"124","author":"T Vanmierlo","year":"2011","unstructured":"Vanmierlo T, Popp J, K\u00f6lsch H, Friedrichs S, Jessen F, Stoffel-Wagner B, Bertsch T, Hartmann T, Maier W, von Bergmann K, et al. The plant sterol brassicasterol as additional CSF biomarker in Alzheimer\u2019s disease. Acta Psychiatr Scand. 2011;124(3):184\u201392.","journal-title":"Acta Psychiatr Scand"},{"key":"1424_CR15","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.freeradbiomed.2016.10.008","volume":"101","author":"M Doria","year":"2016","unstructured":"Doria M, Maugest L, Moreau T, Lizard G, Vejux A. Contribution of cholesterol and oxysterols to the pathophysiology of Parkinson\u2019s disease. Free Radic Biol Med. 2016;101:393\u2013400.","journal-title":"Free Radic Biol Med"},{"key":"1424_CR16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.plipres.2015.01.003","volume":"58","author":"T Vanmierlo","year":"2015","unstructured":"Vanmierlo T, Bogie JF, Mailleux J, Vanmol J, L\u00fctjohann D, Mulder M, Hendriks JJ. Plant sterols: friend or foe in CNS disorders? Prog Lipid Res. 2015;58:26\u201339.","journal-title":"Prog Lipid Res"},{"issue":"19","key":"1424_CR17","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1001\/jama.2017.17219","volume":"318","author":"CA Emdin","year":"2017","unstructured":"Emdin CA, Khera AV, Kathiresan S. Mendelian randomization. JAMA. 2017;318(19):1925\u20136.","journal-title":"JAMA"},{"key":"1424_CR18","doi-asserted-by":"crossref","unstructured":"Sanderson E, Glymour MM, Holmes MV, Kang H, Morrison J, Munaf\u00f2 MR, Palmer T, Schooling CM, Wallace C, Zhao Q, et al. Mendelian randomization. Nat Rev Methods Primers. 2022;2:6.","DOI":"10.1038\/s43586-021-00092-5"},{"issue":"1","key":"1424_CR19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41467-021-27706-6","volume":"13","author":"M Scholz","year":"2022","unstructured":"Scholz M, Horn K, Pott J, Gross A, Kleber ME, Delgado GE, Mishra PP, Kirsten H, Gieger C, M\u00fcller-Nurasyid M, et al. Genome-wide meta-analysis of phytosterols reveals five novel loci and a detrimental effect on coronary atherosclerosis. Nat Commun. 2022;13(1):143.","journal-title":"Nat Commun"},{"issue":"3","key":"1424_CR20","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, et al. Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing. Nat Genet. 2019;51(3):414\u201330.","journal-title":"Nat Genet"},{"issue":"3","key":"1424_CR21","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41588-020-00776-w","volume":"53","author":"J Schwartzentruber","year":"2021","unstructured":"Schwartzentruber J, Cooper S, Liu JZ, Barrio-Hernandez I, Bello E, Kumasaka N, Young AMH, Franklin RJM, Johnson T, Estrada K, et al. Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer\u2019s disease risk genes. Nat Genet. 2021;53(3):392\u2013402.","journal-title":"Nat Genet"},{"issue":"12","key":"1424_CR22","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls MA, Blauwendraat C, Vallerga CL, Heilbron K, Bandres-Ciga S, Chang D, Tan M, Kia DA, Noyce AJ, Xue A, et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 2019;18(12):1091\u2013102.","journal-title":"Lancet Neurol"},{"issue":"6","key":"1424_CR23","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/mds.27659","volume":"34","author":"C Blauwendraat","year":"2019","unstructured":"Blauwendraat C, Heilbron K, Vallerga CL, Bandres-Ciga S, von Coelln R, Pihlstr\u00f8m L, Sim\u00f3n-S\u00e1nchez J, Schulte C, Sharma M, Krohn L, et al. Parkinson\u2019s disease age at onset genome-wide association study: defining heritability, genetic loci, and \u03b1-synuclein mechanisms. Mov Disord. 2019;34(6):866\u201375.","journal-title":"Mov Disord"},{"issue":"7965","key":"1424_CR24","doi-asserted-by":"publisher","first-page":"E19","DOI":"10.1038\/s41586-023-06194-2","volume":"618","author":"SE Graham","year":"2023","unstructured":"Graham SE, Clarke SL, Wu KH, Kanoni S, Zajac GJM, Ramdas S, Surakka I, Ntalla I, Vedantam S, Winkler TW, et al. Author correction: the power of genetic diversity in genome-wide association studies of lipids. Nature. 2023;618(7965):E19\u2013e20.","journal-title":"Nature"},{"issue":"16","key":"1424_CR25","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","volume":"326","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova VW, Richmond RC, Woolf BAR, Yarmolinsky J, Davies NM, Swanson SA, VanderWeele TJ, Higgins JPT, Timpson NJ, Dimou N, et al. Strengthening the reporting of Observational studies in Epidemiology using mendelian randomization: the STROBE-MR Statement. JAMA. 2021;326(16):1614\u201321.","journal-title":"JAMA"},{"issue":"5","key":"1424_CR26","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","volume":"32","author":"S Burgess","year":"2017","unstructured":"Burgess S, Thompson SG. Interpreting findings from mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017;32(5):377\u201389.","journal-title":"Eur J Epidemiol"},{"issue":"5","key":"1424_CR27","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693\u20138.","journal-title":"Nat Genet"},{"key":"1424_CR28","doi-asserted-by":"crossref","unstructured":"Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, Laurin C, Burgess S, Bowden J, Langdon R, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7:e34408.","DOI":"10.7554\/eLife.34408"},{"key":"1424_CR29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.plipres.2018.04.001","volume":"70","author":"RA Moreau","year":"2018","unstructured":"Moreau RA, Nystr\u00f6m L, Whitaker BD, Winkler-Moser JK, Baer DJ, Gebauer SK, Hicks KB. Phytosterols and their derivatives: structural diversity, distribution, metabolism, analysis, and health-promoting uses. Prog Lipid Res. 2018;70:35\u201361.","journal-title":"Prog Lipid Res"},{"issue":"6","key":"1424_CR30","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1111\/febs.16344","volume":"290","author":"F Yin","year":"2023","unstructured":"Yin F. Lipid metabolism and Alzheimer\u2019s disease: clinical evidence, mechanistic link and therapeutic promise. Febs j. 2023;290(6):1420\u201353.","journal-title":"Febs j"},{"issue":"9","key":"1424_CR31","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1038\/s12276-020-00503-9","volume":"52","author":"DS Jo","year":"2020","unstructured":"Jo DS, Park NY, Cho DH. Peroxisome quality control and dysregulated lipid metabolism in neurodegenerative diseases. Exp Mol Med. 2020;52(9):1486\u201395.","journal-title":"Exp Mol Med"},{"issue":"10","key":"1424_CR32","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1093\/brain\/awac176","volume":"145","author":"J Galper","year":"2022","unstructured":"Galper J, Dean NJ, Pickford R, Lewis SJG, Halliday GM, Kim WS, Dzamko N. Lipid pathway dysfunction is prevalent in patients with Parkinson\u2019s disease. Brain. 2022;145(10):3472\u201387.","journal-title":"Brain"},{"key":"1424_CR33","doi-asserted-by":"crossref","unstructured":"Sharma N, Tan MA, An SSA. Phytosterols: potential metabolic modulators in neurodegenerative diseases. Int J Mol Sci. 2021;22(22):12255.","DOI":"10.3390\/ijms222212255"},{"issue":"4","key":"1424_CR34","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.1021\/acsomega.2c06098","volume":"8","author":"A Babazadeh","year":"2023","unstructured":"Babazadeh A, Vahed FM, Liu Q, Siddiqui SA, Kharazmi MS, Jafari SM. Natural bioactive molecules as Neuromedicines for the Treatment\/Prevention of Neurodegenerative Diseases. ACS Omega. 2023;8(4):3667\u201383.","journal-title":"ACS Omega"},{"key":"1424_CR35","doi-asserted-by":"publisher","first-page":"j1648","DOI":"10.1136\/bmj.j1648","volume":"357","author":"M Benn","year":"2017","unstructured":"Benn M, Nordestgaard BG, Frikke-Schmidt R, Tybj\u00e6rg-Hansen A. Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer\u2019s disease and Parkinson\u2019s disease: mendelian randomisation study. BMJ. 2017;357:j1648.","journal-title":"BMJ"},{"issue":"1","key":"1424_CR36","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13195-020-00712-4","volume":"12","author":"S Emrani","year":"2020","unstructured":"Emrani S, Arain HA, DeMarshall C, Nuriel T. APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer\u2019s disease: a systematic review. Alzheimers Res Ther. 2020;12(1):141.","journal-title":"Alzheimers Res Ther"},{"issue":"8","key":"1424_CR37","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/s41593-022-01127-0","volume":"25","author":"CC Liu","year":"2022","unstructured":"Liu CC, Zhao J, Fu Y, Inoue Y, Ren Y, Chen Y, Doss SV, Shue F, Jeevaratnam S, Bastea L, et al. Peripheral apoE4 enhances Alzheimer\u2019s pathology and impairs cognition by compromising cerebrovascular function. Nat Neurosci. 2022;25(8):1020\u201333.","journal-title":"Nat Neurosci"},{"issue":"11","key":"1424_CR38","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1038\/s41590-023-01627-6","volume":"24","author":"Z Yin","year":"2023","unstructured":"Yin Z, Rosenzweig N, Kleemann KL, Zhang X, Brand\u00e3o W, Margeta MA, Schroeder C, Sivanathan KN, Silveira S, Gauthier C, et al. APOE4 impairs the microglial response in Alzheimer\u2019s disease by inducing TGF\u03b2-mediated checkpoints. Nat Immunol. 2023;24(11):1839\u201353.","journal-title":"Nat Immunol"},{"issue":"22","key":"1424_CR39","doi-asserted-by":"publisher","first-page":"e2288","DOI":"10.1212\/WNL.0000000000207923","volume":"101","author":"Z Zhou","year":"2023","unstructured":"Zhou Z, Ryan J, Tonkin AM, Zoungas S, Lacaze P, Wolfe R, Orchard SG, Murray AM, McNeil JJ, Yu C, et al. Association between Triglycerides and Risk of Dementia in Community-Dwelling older adults: a prospective cohort study. Neurology. 2023;101(22):e2288\u201399.","journal-title":"Neurology"},{"issue":"20","key":"1424_CR40","doi-asserted-by":"publisher","first-page":"e2088","DOI":"10.1212\/WNL.0000000000009436","volume":"94","author":"MM Bernath","year":"2020","unstructured":"Bernath MM, Bhattacharyya S, Nho K, Barupal DK, Fiehn O, Baillie R, Risacher SL, Arnold M, Jacobson T, Trojanowski JQ, et al. Serum triglycerides in Alzheimer disease: relation to neuroimaging and CSF biomarkers. Neurology. 2020;94(20):e2088\u201398.","journal-title":"Neurology"},{"issue":"12","key":"1424_CR41","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1001\/archneurol.2010.297","volume":"67","author":"C Reitz","year":"2010","unstructured":"Reitz C, Tang MX, Schupf N, Manly JJ, Mayeux R, Luchsinger JA. Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease. Arch Neurol. 2010;67(12):1491\u20137.","journal-title":"Arch Neurol"},{"issue":"12","key":"1424_CR42","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1111\/jgs.15581","volume":"66","author":"ZA Marcum","year":"2018","unstructured":"Marcum ZA, Walker R, Bobb JF, Sin MK, Gray SL, Bowen JD, McCormick W, McCurry SM, Crane PK, Larson EB. Serum cholesterol and Incident Alzheimer\u2019s Disease: findings from the adult changes in Thought Study. J Am Geriatr Soc. 2018;66(12):2344\u201352.","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"1424_CR43","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3233\/JAD-215250","volume":"86","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Zhang M, Chen Y, Cao Y, Dong G. Nonlinear relationship of Non-high-density Lipoprotein Cholesterol and cognitive function in American elders: a cross-sectional NHANES Study (2011\u20132014). J Alzheimers Dis. 2022;86(1):125\u201334.","journal-title":"J Alzheimers Dis"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-024-01424-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-024-01424-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-024-01424-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T00:03:09Z","timestamp":1709942589000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-024-01424-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,9]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1424"],"URL":"https:\/\/doi.org\/10.1186\/s13195-024-01424-9","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,9]]},"assertion":[{"value":"3 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed based on publicly available data and no separate ethical approval was required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}